Interleukin-1 inhibitors for chronic gout

  • Sivera F
  • Wechalekar M
  • Andrés M
  • et al.
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:To assess the efficacy and safety of interleukin-1 inhibitors (anakinra, canakinumab, rilonacept) in chronic gout.

Cite

CITATION STYLE

APA

Sivera, F., Wechalekar, M. D., Andrés, M., Buchbinder, R., & Carmona, L. (2012). Interleukin-1 inhibitors for chronic gout. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd009994

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free